In its last few days of power, the Biden administration is expected to officially propose a limit on nicotine in cigarettes.

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

Esther Rajavelu Appointed Interim President and Chief Executive Officer, Frank Thomas Appointed Chairman of the Board Interim Changes to Leadership Follow the Company's Response to a Wells Notice from ...

American science and medicine are becoming increasingly infiltrated by Diversity, Equity, and Inclusion (DEI), to their ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

The office of the U.S. Trade Representative warned that there’s a risk of ineffective or dangerous drugs from online ...

Robert F Kennedy Jr could be America's new health secretary, overseeing food safety under Donald Trump? What could it mean ...

Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance ...

- Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and stabilization ...

Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...